Key result
ANGPTL4 expression was significantly higher at the primary site in OSCC cases with lymph node metastasis and promoted cell invasion, contributing to metastatic potential.
ANGPTL4 contributes to OSCC metastasis by stimulating cell invasion and may serve as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ANGPTL4-targeted therapy in metastatic OSCC; animal data leave open human translation and require clinical validation.
Lymph node metastasis is a major factor for poor prognosis in oral squamous cell carcinoma (OSCC). However, the molecular mechanisms of lymph node metastasis are unclear. We determined that angiopoietin-like protein 4 (ANGPTL4) mRNA and protein expression were increased in OSCC cells established from the primary site in metastatic cases. In addition, ANGPTL4 expression in biopsy specimens was correlated with the presence of lymph node metastasis. Therefore, our initial findings suggest that OSCC cells expressing ANGPTL4 may possess metastatic ability. Furthermore, cell culture supernatants from OSCC cells that metastasized to the lymph node contain ANGPTL4 and promote invasive ability. These findings suggest that secreted ANGPTL4 may affect the invasive ability of OSCC. Moreover, the rates of positive ANGPTL4 expression at the primary site were significantly higher in the lymph node metastasis group. These results demonstrate that ANGPTL4 contributes to OSCC metastasis by stimulating cell invasion. Therefore, ANGPTL4 is a potential therapeutic target for preventing cancer metastasis.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2014) studied oral squamous cell carcinoma (OSCC). ANGPTL4 expression was evaluated on lymph node metastasis and cell invasion. ANGPTL4 expression was significantly higher at the primary site in OSCC cases with lymph node metastasis and promoted cell invasion, contributing to metastatic potential.
Synapse has enriched 10 related papers. Consider them for comparative context: